Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Jefferson City, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Jefferson City, TN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Kingsport, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Kingsport, TN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Knoxville, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Knoxville, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Memphis, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Memphis, TN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Nashville, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Arlington, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Arlington, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Austin, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Austin, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Austin, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Austin, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Austin, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Austin, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Channelview, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Channelview, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Dallas, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Dallas, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Dallas, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Dallas, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Gonzales, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Gonzales, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Houston, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Houston, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Houston, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Houston, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Houston, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Houston, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Pharr, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Pharr, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Plano, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Plano, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Plano, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Plano, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
San Antonio, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
San Antonio, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Draper, UT
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Draper, UT
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Newport News, VA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Newport News, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Sterling, VA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Sterling, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Anniston, AL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Anniston, AL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Fort Lauderdale, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Saint Cloud, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Saint Cloud, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Saint Petersburg, FL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Evansville, IN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Evansville, IN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Monroe, LA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Monroe, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Saint Louis, MO
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Omaha, NE
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Omaha, NE
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Stateline, NV
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Stateline, NV
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Upper Saint Clair, PA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Upper Saint Clair, PA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Moncks Corner, SC
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Moncks Corner, SC
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Franklin, TN
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Franklin, TN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Carrollton, TX
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Carrollton, TX
Click here to add this to my saved trials
A Study of the Effect of SYN-010 on Subjects With IBS-C
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Dose Study of the Effect of Two Dosage Strengths of SYN-010 Compared With Placebo on Breath Methane Production in Breath Methane-Positive Subjects With IBS-C
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A Study of the Effect of SYN-010 on Subjects With IBS-C
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Dose Study of the Effect of Two Dosage Strengths of SYN-010 Compared With Placebo on Breath Methane Production in Breath Methane-Positive Subjects With IBS-C
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
HealthStar Research, LLC
mi
from
Hot Springs, AR
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
HealthStar Research, LLC
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
Advanced Research Center, Inc.
mi
from
Anaheim, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
Advanced Research Center, Inc.
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
Kindred Medical Institute For Clinical Trials, LLC
mi
from
Corona, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
Kindred Medical Institute For Clinical Trials, LLC
mi
from
Corona, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
WCCT Global, LLC
mi
from
Costa Mesa, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
WCCT Global, LLC
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
Ark Clinical Research
mi
from
Long Beach, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
Ark Clinical Research
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
Actca
mi
from
Los Angeles, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
Actca
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
Orange County Research Institute
mi
from
Ontario, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
Orange County Research Institute
mi
from
Ontario, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Trials, LLC.
mi
from
Paramount, CA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Trials, LLC.
mi
from
Paramount, CA
Click here to add this to my saved trials